CAT No: CP25628
CAS No:21947-32-0
Synonyms/Alias:Boc-Nle-OHDCHA;21947-32-0;N-((tert-bUtoxy)carbonyl)-L-norleucine,compoundwithdicyclohexylamine(1:1);boc-nle-oh.dcha;Boc-Nle-OHCHA;Boc-Nle-OH?DCHA;CTK1A6914;MolPort-016-580-270;C23H44N2O4;EINECS244-673-0;1108AB;AKOS015903280;CB-1692;RTR-010289;AK-81138;Boc-L-Nle-OH(dicyclohexylammonium)salt;KB-300022;TR-010289;ST24046235;K-6223;I14-18575;N-(tert-Butoxycarbonyl)-L-norleucine-N-cyclohexylcyclohexanamine(1:1);L-Norleucine,N-[(1,1-dimethylethoxy)carbonyl]-,compd.withN-cyclohexylcyclohexanamine(1:1)
Chemical Name:N-alpha-t-Butyloxycarbonyl-L-norleucine dicyclohexylamine, (S)-N-alpha-Boc-2-aminohexanoic acid
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.